Ying WangAssistant Professor
Dr. Wang received her BSc (2006) and MSc (2008) in Pharmaceutical Sciences, Wuhan University. She worked as an Associate Scientist at Shanghai ChemPartner Co. Ltd (2008-2009), where her research focused on pre-clinical screening for anti-cancer pharmaceutical candidates using human tumor biospecimens. She continued her academic training at University of British Columbia in 2009 as a PhD student at Faculty of Pharmaceutical Sciences and then as a Postdoctoral Fellow at the Centre for Heart Lung Innovation in 2014. She was awarded the Elaine W. Raines Early Career Investigator Award by the American Heart Association in 2016 and joined the PlaqOmics Leducq Foundation Trans-Atlantic Network in 2018 during her Postdoctoral training at Stanford University. Dr. Wang began her academic appointment as Assistant Professor at the University of British Columbia in March 2021.
Education & Training
- Post-doctoral fellow, Department of Vascular Surgery, Stanford University, Stanford, US. 2020
- Post-doctoral fellow, Department of Medicine, University of British Columbia, Vancouver. 2017
- PhD, Pharmaceutical Sciences, University of British Columbia. 2014
- MSc, Pharmacology, Wuhan University, China. 2008
- BSc, Pharmaceutical Sciences, Wuhan University, China. 2006
Area of Interest
Dr. Wang’s research is focused on studying cell-cell and cell-microenvironment interactions to determine why diseased cells accumulate in the atherosclerotic lesions and how we can remove them. ‘Functional omics on a tissue slide’ is the current theme of Dr. Wang’s research. With a combination of biobank associated studies, spatial biology technology, and molecular biology, researchers in the Wang Lab aim to develop new therapeutic and diagnostic tools for better treatment and prediction of atherosclerotic disease.
- Maria Elishaev, MSc
- Xiangyu Gao, MSc